Breaking news on cervical cancer and HPV
US Pediatricians Recommend Routine HPV Vaccination For Boys published
Sat, 04 Feb 2012 00:00:00 PST
As part of a revised standard published this week, the American Academy of Pediatrics says boys should be routinely vaccinated against the human papillomavirus (HPV), a common virus that is spread through sexual contact. Although there are dozens of types of HPV, vaccines can protect both male and females against some of the more common types that can lead to disease and cancer...
Recommendations For HPV And Hepatitis B Vaccinations Broadened By 2012 Adult Immunization Schedule published
Thu, 02 Feb 2012 01:00:00 PST
The CDC's Advisory Committee on Immunization Practices (ACIP) now recommends routine HPV vaccination for males aged 11 to 12 years and catch-up vaccination for males aged 13 to 21. These are just two of the changes to the 2012 Recommended Adult Immunization Schedule published February 1 in Annals of Internal Medicine, the flagship journal of the American College of Physicians (ACP)...
HPV Vaccine Not Linked To Autoimmune Disorders, Study published
Sun, 29 Jan 2012 00:00:00 PST
A two-year study of nearly 190,000 girls and women, finds that Gardasil, the human papillomavirus (HPV) vaccine made by Merck & Co, does not trigger autoimmune disorders such as lupus, rheumatoid arthritis, type 1 diabetes and multiple sclerosis. The results are published in the Journal of Internal Medicine...
Cancer Screening Rates Low Among Ethnic Groups, USA published
Fri, 27 Jan 2012 10:00:00 PST
Not only are relatively few Americans screened for cancer, but there are considerable disparities between ethnic and racial groups in the country, says a new report issued by NCI (National Cancer Institute) and the CDCF (Centers for Disease Control and Prevention). The authors added that screening rates are especially low among Hispanic and Asian Americans...
Men At Greater Risk For Oral HPV Infection, HPV-Related Cancers published
Fri, 27 Jan 2012 04:00:00 PST
Oral HPV infection is more common among men than women, explaining why men are more prone than women to develop an HPV related head and neck cancer, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM...
2-Year Study Finds Gardasil Does Not Trigger Autoimmune Conditions After Vaccination published
Fri, 27 Jan 2012 00:00:00 PST
Gardasil, the human papillomavirus vaccine that is now recommended for male and female adolescents and young adults, does not trigger autoimmune conditions such as lupus, rheumatoid arthritis, type 1 diabetes or multiple sclerosis after vaccination in young women, according to a new study in the Journal of Internal Medicine...
Self-HPV Testing Could Be An Effective Cervical Cancer Screening Method published
Thu, 26 Jan 2012 09:00:00 PST
A study published January 23 in the Journal of the National Cancer Institute , has found that self-HPV (human papillomavirus) testing, in low-resource settings, may be a more effective way to screen for cervical cancer than liquid-based cytology (LBC) and visual inspection with acetic acid (VIA). Cervical cancer is one of the most prevalent cancers found in women...
7% Of Americans Have Oral HPV published
Thu, 26 Jan 2012 09:00:00 PST
A study published online in JAMA on Thursday suggests 7% of men and women in the US carry the Human papillomavirus (HPV), the virus that causes a distinct form of cancer that affects the part of the throat that sits at the back of the mouth...
Indications Of A Benefit In Primary HPV Testing published
Thu, 26 Jan 2012 00:00:00 PST
Precursors of cervical cancer can be detected and treated earlier / Risk of over-treatment Studies currently available provide indications and a "hint" that precursors of cervical cancer can be detected and treated earlier, and consequently tumours occur less often, in women who underwent testing for human papillomavirus (HPV)...
Cervical Cancer Screening Via Self-Collection published
Tue, 24 Jan 2012 02:00:00 PST
Human papillomavirus (HPV) testing of self-collected specimens may be a more effective way to screen for cervical cancer in low-resource settings compared to visual inspection with acetic acid (VIA) and liquid-based cytology (LBC), according to a study published in the Journal of the National Cancer Institute...
Aspirin - Ability To Prevent Cervical Cancer In HIV Infected Women published
Fri, 20 Jan 2012 08:00:00 PST
According to a study published in the current issue of the journal Cancer Prevention Research, aspirin should be assessed for its ability to prevent cervical cancer developing in women infected with HIV. Aspirin has the potential to provide considerable benefit for women in Africa, the Caribbean and Latin America, regions where death rates from cervical cancer are extremely high...
Aspirin Merits Testing For Prevention Of Cervical Cancer In HIV-Infected Women published
Fri, 20 Jan 2012 01:00:00 PST
Research conducted by NewYork-Presbyterian Hospital/Weill Cornell Medical Center global health investigators and cancer specialists in New York, Qatar and Haiti suggests that aspirin should be evaluated for its ability to prevent development of cervical cancer in HIV-infected women...
Identifying Patients With Increased Risk From Throat Cancer published
Wed, 18 Jan 2012 00:00:00 PST
Independent of other factors, such as smoking history and HPV status, matted lymph nodes appear to signal increased chance of oropharyngeal cancer spreading to other parts of the body Researchers at the University of Michigan Health System have found a new indicator that may predict which patients with a common type of throat cancer are most likely have the cancer spread to ...
How Obesity Affects Cancer Screening published
Wed, 11 Jan 2012 00:00:00 PST
Researchers in Family and Community Medicine at Thomas Jefferson University recently found that obesity was linked to higher rates of prostate cancer screening across all races/ethnic differences and lower rates of cervical cancer screening, most notably in white women...
Reducing HPV Infection - Single-Sex Vaccination Has Best Effect published
Thu, 05 Jan 2012 08:00:00 PST
According to a study in PLoS Medicine, the most effective strategy to protect against human papillomavirus (HPV) is single-sex vaccination. They also found that it was preferable to vaccinate females instead of men, given that females are the sex with the highest prevaccine prevalence of HPV infection...
During Ovulation, Females May Be More Susceptible To Infection published
Wed, 04 Jan 2012 02:00:00 PST
New research published in the Journal of Leukocyte Biology suggests that high levels of estradiol present prior to ovulation decreases immune system effectiveness resulting in growth and promotion of infection A new research report in the Journal of Leukocyte Biology suggests that a woman's ovarian cycle plays an important role in her susceptibility to infection...
HPV Vaccine Does Not Alter Sexual Behavior published
Sat, 24 Dec 2011 00:00:00 PST
According to a national study by The Centers for Disease Control & Prevention published in the American Journal of Preventive Medicine, contrary to some people's belief, young women receiving recommended vaccinations for the prevention of human papillomavirus (HPV) infection and related cancers do not engage in more sexually risky behavior. Nicole C. Liddon, Ph.D...
FDA Approves Hologic's Cervista High Throughput Automation System For Cervical Cancer Screening published
Sun, 18 Dec 2011 00:00:00 PST
Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today that the U.S...
HPV Vaccine Does Not Appear To Encourage Risky Sexual Behavior published
Sat, 17 Dec 2011 00:00:00 PST
Despite some assumptions to the contrary, young women who receive recommended vaccinations to prevent human papillomavirus (HPV) infection and associated cancers do not engage in more sexually risky behavior. That is the cautious determination of a national study by The Centers for Disease Control & Prevention reported in the American Journal of Preventive Medicine. Lead study author Nicole C...
Detecting Cervical Cancer - HPV DNA Test Is Best published
Fri, 16 Dec 2011 08:00:00 PST
Final results of the POBASCAM trial reveal that for women aged 30+, the human papillomavirus (HPV) DNA test is the optimum cervical cancer screening option. The HPV DNA test prevents more cervical cancers than cytology alone, and detects lesions which cause cervical cancer earlier. Study results provide the strongest evidence to date in favor of using this test in national screening programs...
HPV DNA Testing Advised For Females Over 30 published
Thu, 15 Dec 2011 11:00:00 PST
HPV DNA testing is better than cytology alone in preventing cervical cancer or detecting it early on for women over thirty, researchers reported in The Lancet Oncology. The authors explained, after reporting on the POBASCAM trial, that they now have compelling evidence in favour of routine HPV testing in national screening programs...
HPV Vaccination Change Is A Good Thing, Says British Dental Health Foundation published
Tue, 29 Nov 2011 07:00:00 PST
The Government's plan to switch its Human Papilloma Virus (HPV) vaccination from "Cervarix" to Gardasil" from Sep. 2012, has been welcomed by the British Dental Health Foundation. The leading oral health charity believes that the novel vaccine will deliver increased health benefits and prevent genital warts...
No Link Between Depression, Anxiety And Delayed Resolution Of Abnormal Mammograms, Pap Tests published
Sat, 26 Nov 2011 00:00:00 PST
In what is believed to be the first study of its kind to examine the relationship between pre-existing depression (with and without anxiety) and the amount of time to diagnostically resolve an abnormal mammogram and/or Pap test, researchers from Boston University School of Medicine (BUSM) have found suffering from depression was not associated with a prolonged time to diagnosti...
Benefits Of Cobas® HPV Test For Primary Screening, England published
Fri, 25 Nov 2011 07:00:00 PST
According to an investigation recently published online in The Lancet Oncology, data from a sub-analysis of the Addressing THE Need for Advanced HPV Diagnostics (ATHENA) landmark study, showed that the HPV test Roche cobas, may be used for initial screening of cervical cancer...
Hyperthermia Heat Treatment For Cancer Approved published
Tue, 22 Nov 2011 09:00:00 PST
BSD Medical Corporation's new system of using heat to treat cancer, known as the BSD-2000 Hyperthermia System, which uses "hyper" not "hypo" thermia, has been granted Humanitarian Device Exemption (HDE) marketing approval from the U.S. Food and Drug Administration (FDA)...
)
|
|
